Skip to main content
Table of Contents
Print

Can Cannabis Mask Sleep Apnoea Symptoms and Delay Proper Treatment? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Sleep apnoea is a serious condition, and there is growing concern that cannabis use might interfere with timely diagnosis. Some evidence indicates that cannabis mask apnoea symptoms, potentially leading patients to underestimate their condition and delay seeking medical help. 

Understanding the Impact 

Cannabis can affect alertness and perception of sleep quality, which may make typical OSA indicators like daytime sleepiness less obvious. This could result in a delayed OSA diagnosis with cannabis, as patients and clinicians might not detect the severity of the disorder during routine assessments. 

Reduced Daytime Sleepiness 

By diminishing fatigue and sleepiness, cannabis mask apnoea symptoms, which can obscure the warning signs that usually prompt a clinical evaluation. 

Altered Snoring and Breathing Patterns 

Cannabis may also change breathing patterns during sleep, leading to hidden OSA with cannabis, where patients appear less symptomatic despite persistent airway obstruction. 

Clinical Risks 

Masking symptoms increases the risk of prolonged untreated OSA, potentially worsening cardiovascular, metabolic, and cognitive outcomes. Clinicians should carefully screen for cannabis use when evaluating sleep complaints. 

Awareness that cannabis mask apnoea symptoms can occur is vital. Recognising the potential for delayed OSA diagnosis with cannabis and hidden OSA with cannabis ensures patients receive timely diagnosis and treatment, reducing long-term health risks. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories